These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7223173)

  • 41. Histologic observations on the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometrial carcinoma.
    Varga A; Henriksen E
    Obstet Gynecol; 1965 Nov; 26(5):656-64. PubMed ID: 5855353
    [No Abstract]   [Full Text] [Related]  

  • 42. [Synthetic progestins in combined treatment of cancer of the uterine body].
    Iatskovskai NL
    Vopr Onkol; 1976; 22(3):25-8. PubMed ID: 936523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of progestational agents in treatment of endometrial carcinoma.
    Podratz KC; O'Brien PC; Malkasian GD; Decker DG; Jefferies JA; Edmonson JH
    Obstet Gynecol; 1985 Jul; 66(1):106-10. PubMed ID: 4011061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Model studies on incubated hen's eggs for the detection of synthetic gestagens within the framework of residue determination].
    Scheibner G; Fehlhaber K
    Arch Exp Veterinarmed; 1981; 35(1):57-65. PubMed ID: 6164349
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)].
    Beliaeva LA; Bukhvalov IB; Zheleznov BI; Raĭkhlin NT
    Arkh Patol; 1982; 44(4):18-25. PubMed ID: 7082195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hormonal treatment of myomata (author's transl)].
    Pacin J; Ivan J; Ginelli T; Csonth J
    Cesk Gynekol; 1975 Jun; 40(5):345-6. PubMed ID: 1137876
    [No Abstract]   [Full Text] [Related]  

  • 48. [Specific modification of the proliferation of primary transplanted human uterine carcinoma cells by means of gestagens].
    Tranekjer AS; Rindt W; Brachetti A; Hamann A
    Zentralbl Gynakol; 1970 Jul; 92(27):857-60. PubMed ID: 5497100
    [No Abstract]   [Full Text] [Related]  

  • 49. [Diagnosis and therapy of endometrial cancer (author's transl)].
    Castaño-Almendral A
    Schweiz Rundsch Med Prax; 1974 Feb; 63(5):128-33. PubMed ID: 4420649
    [No Abstract]   [Full Text] [Related]  

  • 50. Progesterone caproate in the treatment of endometrial cancer.
    Sherman AI
    Obstet Gynecol; 1966 Sep; 28(3):309-14. PubMed ID: 4162030
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of progestin therapy on the level of cytoplasmic receptors in patients with cancer of the corpus uteri].
    Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Fel'dkoren BI
    Vopr Onkol; 1989; 35(5):594-8. PubMed ID: 2545046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mechanisms of the antitumor action of gestagens on endometrial cancer].
    Nishida M; Kasahara K; Tsuji T; Kaneko M; Iwasaki H
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2214-22. PubMed ID: 3805831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
    Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormonal treatment of endometrial carcinoma: an overview and new development in biology.
    Satyaswaroop PG; Mortel R
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):997-1001. PubMed ID: 2285611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Occurrence and histological structure of adenocarcinoma of the endocervix after long-term use of oral contraceptives (author's transl)].
    Dallenbach-Hellweg G
    Geburtshilfe Frauenheilkd; 1982 Apr; 42(4):249-55. PubMed ID: 6920328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
    Shenderëva TS; Shvedova LA
    Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preliminary note on histologic changes induced by a new synthetic gestagen (19-nor-17-alpha-hydroxyprogesterone capronate) on adenocarcinoma of the endometrium].
    Vecchione A; Ruozi Berretta L
    Riv Anat Patol Oncol; 1968; 33():431-60. PubMed ID: 5760166
    [No Abstract]   [Full Text] [Related]  

  • 58. [A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer].
    Prianishnikov VA; Bokhman IaV; Chepik OF
    Arkh Patol; 1975; 37(6):19-23. PubMed ID: 176978
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy of an adjuvant norethisterone acetate therapy (NEA) of endometrial carcinoma treated with primary surgery or irradiation].
    Krafft W; Steuckardt R; König EM; Schirmer A; Schmeisser G; Brückmann D
    Zentralbl Gynakol; 1990; 112(16):1023-30. PubMed ID: 2220176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Excretion of follicle-stimulating and steroid hormones in patients with uterine cancer during treatment with 17-hydroxyprogesterone caproate].
    Sharoukhova KS; Vershinina GN; Murav'eva NI; Smirnova KD; Goncharova MG
    Akush Ginekol (Mosk); 1970 Oct; 46(10):9-13. PubMed ID: 5519750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.